Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
S&P 500 and Nasdaq 100: Tech Stocks Lift Futures Ahead of Key Jobs Report
08:27am, Friday, 01'st Nov 2024
Nasdaq 100 futures rise on Amazon, Intel gains; traders await key U.S. jobs data for insights into tech stock momentum.
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Friday, 01'st Nov 2024
CLEVELAND, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awar
SOBRsafe Regains Compliance with Nasdaq Listing Requirements
08:45pm, Thursday, 31'st Oct 2024
DENVER, CO / ACCESSWIRE / October 31, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), provider of next-generation transdermal alcohol detection solutions, today announced that the Company has regai
Nasdaq leads sell-off after Microsoft, Meta earnings prompt Big Tech slide
07:01pm, Thursday, 31'st Oct 2024
To get the latest market news check out finance.yahoo.com The Nasdaq led a tumble in US stocks on Thursday after Meta (META) and Microsoft (MSFT) earnings sparked worries about prospects for Big Techs
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05:31pm, Thursday, 31'st Oct 2024
REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmun
Trident Rings the Nasdaq Opening Bell Following Successful U.S. Listing
04:30pm, Thursday, 31'st Oct 2024
Company Rings Opening Bell to Celebrate Completion of Initial Public Offering and Begins Journey as a Public Company; Shares trade under “TDTH” Ticker Company Rings Opening Bell to Celebrate Compl
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
04:30pm, Thursday, 31'st Oct 2024
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under Nasdaq
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
02:43pm, Thursday, 31'st Oct 2024
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday.
Nasdaq Index Under Pressure as Microsoft, Meta Earnings Disappoint Investors
10:10am, Thursday, 31'st Oct 2024
Nasdaq falls as Microsoft, Meta miss earnings targets; Fed's stable inflation data adds to market uncertainty ahead of next rate decision.
Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results
09:56am, Thursday, 31'st Oct 2024
U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday.
Nasdaq, Dow Jones and S&P 500 Forecast – US Indices Continue to See Hesitation
08:23am, Thursday, 31'st Oct 2024
The US Indices have pulled back a bit in the early hours of Thursday, as we await the Non-Farm Payroll results to get an idea where the stock markets might go running to.
23andMe Regains Compliance With Nasdaq Listing Requirements
05:00pm, Wednesday, 30'th Oct 2024
SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the “Company” or “23andMe”), a leading human genetics and preventive health company, today announced that
S&P500 and Nasdaq Index: Cloud Gains Lift Alphabet, but AMD Drags on Market
01:39pm, Wednesday, 30'th Oct 2024
Alphabet leads tech as Nasdaq hits highs, while AMD and Super Micro slump on earnings misses. Mixed signals keep investors cautious on US stock outlook.
Nasdaq, Dow Jones and S&P 500 Forecast – US Indices Continues to Churn
10:11am, Wednesday, 30'th Oct 2024
The US indices continue to see a lot of noisy behavior, but at this point in time, it looks like we are waiting to see what happens in the Non-Farm Payroll numbers on Friday, and of course the US Pres
BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
06:00am, Wednesday, 30'th Oct 2024
NEW YORK , Oct. 30, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that on October 29,
